𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Incidence of cardiovascular disease in Type 1 (insulin-dependent) diabetic subjects with and without diabetic nephropathy in Finland

✍ Scribed by J. Tuomilehto; K. Borch-Johnsen; A. Molarius; T. Forsén; D. Rastenyte; C. Sarti; A. Reunanen


Publisher
Springer
Year
1998
Tongue
English
Weight
173 KB
Volume
41
Category
Article
ISSN
0012-186X

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Lack of familial predisposition to cardi
✍ K. Nørgaard; E. R. Mathiesen; E. Hommel; J. S. Jensen; H. -H. Parving 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 289 KB

A familial predisposition has been proposed as a major determinant of the increased morbidity and mortality from cardiovascular disease demonstrated in Type 1 (insulin-dependent) diabetic patients with nephropathy. We assessed this concept by studying 91 parents of Type 1 diabetic patients with neph

Left Ventricular Hypertrophy in Non-insu
✍ Nielsen, F.S; Ali, S.; Rossing, P.; Bang, L.E.; Svendsen, T.L.; Gall, M.-A.; Smi 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB 👁 2 views

The aim of our cross-sectional case-control study was to evaluate putative mechanisms of the increased cardiac morbidity and mortality in NIDDM patients with or without diabetic nephropathy. Fifty-one NIDDM patients with diabetic nephropathy (38 males, age 61 ± 8 years, group 1), 53 NIDDM patients w

Erythrocyte sodium-lithium countertransp
✍ L. D. Elving; J. F. M. Wetzels; E. de Nobel; J. H. M. Berden 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 276 KB

We studied erythrocyte sodium-lithium countertransport in 33 patients with Type 1 (insulin-dependent) diabetes mellitus with diabetic nephropathy, 18 patients with Type 1 diabetes without diabetic nephropathy and in 42 non-diabetic patients with various other renal diseases. No significant differenc

Effects of acetazolamide on kidney funct
✍ P. Skøtt; E. Hommel; N. E. Bruun; S. Arnold-Larsen; H. -H. Parving 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 582 KB

We investigated the effects of 3 days treatment with acetazolamide 250 mg three times daily on kidney function in 8 Type 1 (insulin-dependent) diabetic patients with nephropathy, and in 7 healthy subjects in a double-blind placebo controlled cross-over study. Glomerular filtration rate and extracell